The National Hemophilia Foundation's (NHF) Medical and Scientific Advisory Council (MASAC) issued the following recommendations on April 22, 2006 and the NHF Board of Directors subsequently approved them on June 3, 2006. These documents are available on the NHF Web site.

MASAC Document #167: MASAC Recommendation Regarding the Use of Bypassing Agents in Patients with Hemophilia A or B and Inhibitors

MASAC Document # 168: MASAC Recommendation Regarding Access to Care
For Patients with Bleeding Disorders

MASAC Document #169 (Replaces #106): MASAC Recommendation Regarding the Use of Recombinant Clotting Factor Products with Respect to Pathogen Transmission

MASAC Document #170 (Replaces #117): MASAC Recommendation Concerning Prophylaxis (Regular Administration of Clotting Factor Concentrate to Prevent Bleeding)

To request a copy of any or all of the new recommendations, contact HANDI: 800.424.2634 (option two) or handi@hemophilia.org.